Male factor contributes to roughly half of all infertility cases. The test that identifies it costs less than a decent dinner, takes about an hour of your time, involves no needles, no anaesthetic and no procedure of any kind – and the average Indian couple does not do it until they are two years into trying.
In that same two years, the woman has usually had blood drawn repeatedly, been scanned transvaginally more times than she can count, possibly had a hysterosalpingogram – an X-ray procedure involving dye pushed through the fallopian tubes, which is genuinely uncomfortable – and in some cases a diagnostic laparoscopy under general anaesthetic.
Meanwhile the least invasive test in the entire fertility workup has not been done.
That is not a clinical decision. Nobody sat down and reasoned their way to it. It is a cultural one, and it is worth naming plainly.
Say the actual reason out loud
The delay happens because in a large number of Indian families, infertility is assumed to be the woman’s problem until proven otherwise, and a semen analysis is heard not as a test but as an accusation.
Men refuse it. Mothers-in-law discourage it. Couples agree to “try a few more months” repeatedly. Some men agree in the consulting room and then do not go. Occasionally a wife will ask the doctor privately to suggest it so that the idea does not appear to have come from her.
Every andrologist in this country has watched all of the above happen, more than once, in the same week.
There is no version of this article that is useful while tiptoeing around that, so: a semen analysis is a laboratory measurement of a sample. It is not a verdict on masculinity, virility, sexual performance or anything else a person might be worried it says. Sperm production and sexual function are governed by largely different systems – a man with a normal sex drive and no erectile difficulty whatsoever can have a count of near zero, and frequently does. The two things are not the same, and treating them as the same is what costs couples years.
What the test actually measures
A sample is produced at the laboratory after two to seven days of abstinence and assessed within an hour. The main parameters, against the WHO 6th edition reference limits:
| Parameter | What it means | WHO 6th ed. lower reference limit |
|---|---|---|
| Semen volume | Total fluid produced | 1.4 ml |
| Sperm concentration | Sperm per millilitre | 16 million/ml |
| Total sperm number | Concentration × volume | 39 million per ejaculate |
| Total motility | Proportion moving at all | 42% |
| Progressive motility | Proportion moving purposefully forward | 30% |
| Morphology (strict criteria) | Proportion of normal shape | 4% |
| Vitality | Proportion alive | 54% |
These are reference limits, not pass marks. They were derived from men who conceived within a year – the fifth percentile of that group. Men below them conceive naturally all the time, and men above them sometimes do not.
Morphology is where most unnecessary panic occurs. A 4% threshold sounds alarming to anyone reading it cold, but it reflects the strict criteria used since the fifth edition, under which the vast majority of sperm in a perfectly fertile man are classified abnormal. Four per cent normal forms is not a catastrophe. It is the reference point.
One abnormal result is not a diagnosis
This matters more than anything else in the article, and it is routinely mishandled.
Sperm production runs on a cycle of roughly seventy-two days. What is measured today reflects conditions two to three months ago. A viral fever, a course of antibiotics, a stretch of bad sleep, heavy work stress, a recent bout of COVID, a hot tub habit, or simply a badly timed abstinence interval can all depress a single sample well below reference.
So a low result requires a repeat at six to twelve weeks, at the same laboratory where possible, before it means anything at all. Plenty of men are told at a diagnostic lab that they have a problem, spend three months believing it, and produce a completely normal second sample.
The exception is azoospermia – no sperm found. That still needs confirmation on a second sample with proper centrifugation of the pellet, but it warrants moving to specialist assessment quickly rather than waiting and hoping. Where a repeat does confirm an abnormality, male infertility evaluation and treatment is where the useful part begins, because the follow-up questions – hormonal, structural, genetic – are what determine whether this is fixable.
A good deal of it is fixable
Worth knowing before the test, because it changes how frightening the test feels:
Varicocele – dilated veins in the scrotum, present in a meaningful share of men with abnormal parameters. Correctable surgically, with improvement in parameters in a majority of properly selected cases.
Hormonal causes – hypogonadotropic hypogonadism and similar. Among the most treatable conditions in all of reproductive medicine; medical therapy can restore production from essentially nothing.
Infection or inflammation – treated with a course of antibiotics, with parameters reassessed afterwards.
Obstruction – sperm are being produced but cannot get out, whether from a previous vasectomy, an infection, or a congenital absence of the vas. Surgically bypassable, or sperm can be retrieved directly for ICSI.
Lifestyle and exposure – smoking, obesity, alcohol, anabolic steroids, occupational heat, certain medications. Slow to change and unglamorous, but real.
Unexplained severe deficiency – even here, ICSI needs a single viable sperm per egg. A count that would have ended the conversation thirty years ago frequently does not now.
What to actually do
If you have been trying for a year without success – six months if your partner is over thirty-five – both of you get tested, in the same week, at the same time. Not her first and him later if nothing turns up.
Do it in the same week because it is faster, cheaper and considerably kinder. The alternative is two years of invasive investigation of one person while the obvious question goes unasked, and a result that could have been found on day one.
The test is easy. The conversation is the hard part. Have it anyway.
Byline: [Named Cloudnine andrologist / consultant urologist – MBBS, MS (General Surgery), MCh/DNB (Urology), with andrology practice]
[Author bio: one line on the specialist’s andrology practice + brand link to cloudninefertility.com]
Build notes
On naming the stigma. The brief called for it directly, and it has its own section near the top rather than a passing mention, because the euphemistic treatment of this topic across the Indian web is exactly the gap the piece is meant to fill. The line separating sexual function from sperm production is doing the heaviest lifting in the article – it is the specific misconception driving the refusal, and it is rarely stated plainly anywhere findable.
Anchor. Used as briefed – “male infertility evaluation and treatment”, not exact-match. Placed at roughly 70% depth, at the point where a reader with a confirmed abnormal result is looking for what happens next. That is the highest-intent moment in the piece.
Reference values. WHO 6th edition (2021) limits. Worth having the consultant confirm the lab reports against 6th ed. rather than 5th before publication – some Indian labs still use 5th edition, and the volume and concentration limits differ slightly. If the reviewing specialist prefers, the table can carry both columns.
Cannibalisation. Clean as briefed. The piece never uses “male infertility treatment” as a standalone phrase and carries no treatment-cost or clinic-selection framing. It owns “who gets tested first” and “what a semen analysis measures” only.
Byline. Non-negotiable per the brief and left as a placeholder for the same reason as OP-01 and OP-02. The stigma section in particular needs a real clinician’s name behind it – it reads as authoritative because a practising andrologist is saying it, and it reads quite differently without one.